Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 29 entries
Sorted by: Best Match Show Resources per page
O-0544 Exenatide once-weekly versus twice-daily: comparison of diurnal and postprandial glucose patterns using continuous glucose monitoring and ambulatory glucose profile analysis.

Canadian journal of diabetes

Mazze R, Strock E, Cuddihy R, Morgan B.
PMID: 25998595
Can J Diabetes. 2009;33(3):210-1. doi: 10.1016/S1499-2671(09)33074-9. Epub 2012 Dec 10.

No abstract available.

Cite
Mazze R, Strock E, Cuddihy R, et al. O-0544 Exenatide once-weekly versus twice-daily: comparison of diurnal and postprandial glucose patterns using continuous glucose monitoring and ambulatory glucose profile analysis. Can J Diabetes. 2012;33(3):210-1doi: 10.1016/S1499-2671(09)33074-9.
Mazze, R., Strock, E., Cuddihy, R., & Morgan, B. (2009). O-0544 Exenatide once-weekly versus twice-daily: comparison of diurnal and postprandial glucose patterns using continuous glucose monitoring and ambulatory glucose profile analysis. Canadian journal of diabetes, 33(3), 210-1. https://doi.org/10.1016/S1499-2671(09)33074-9
Mazze, R, et al. "O-0544 Exenatide once-weekly versus twice-daily: comparison of diurnal and postprandial glucose patterns using continuous glucose monitoring and ambulatory glucose profile analysis." Canadian journal of diabetes vol. 33,3 (2009): 210-1. doi: https://doi.org/10.1016/S1499-2671(09)33074-9
Mazze R, Strock E, Cuddihy R, Morgan B. O-0544 Exenatide once-weekly versus twice-daily: comparison of diurnal and postprandial glucose patterns using continuous glucose monitoring and ambulatory glucose profile analysis. Can J Diabetes. 2009;33(3):210-1. doi: 10.1016/S1499-2671(09)33074-9. Epub 2012 Dec 10. PMID: 25998595.
Copy Download .nbib Format: NLM
Leveraging data and new digital tools to prepare for the next pandemic.

Lancet (London, England)

Davies SC, Audi H, Cuddihy M.
PMID: 33812472
Lancet. 2021 Apr 10;397(10282):1349-1350. doi: 10.1016/S0140-6736(21)00680-2. Epub 2021 Apr 01.

No abstract available.

Cite
Davies SC, Audi H, Cuddihy M. Leveraging data and new digital tools to prepare for the next pandemic. Lancet. 2021;397(10282):1349-1350doi: 10.1016/S0140-6736(21)00680-2.
Davies, S. C., Audi, H., & Cuddihy, M. (2021). Leveraging data and new digital tools to prepare for the next pandemic. Lancet (London, England), 397(10282), 1349-1350. https://doi.org/10.1016/S0140-6736(21)00680-2
Davies, Sally C, et al. "Leveraging data and new digital tools to prepare for the next pandemic." Lancet (London, England) vol. 397,10282 (2021): 1349-1350. doi: https://doi.org/10.1016/S0140-6736(21)00680-2
Davies SC, Audi H, Cuddihy M. Leveraging data and new digital tools to prepare for the next pandemic. Lancet. 2021 Apr 10;397(10282):1349-1350. doi: 10.1016/S0140-6736(21)00680-2. Epub 2021 Apr 01. PMID: 33812472.
Copy Download .nbib Format: NLM
Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study.

The Lancet regional health. Europe

Bennett KE, Mullooly M, O'Loughlin M, Fitzgerald M, O'Donnell J, O'Connor L, Oza A, Cuddihy J.
PMID: 33880459
Lancet Reg Health Eur. 2021 Jun;5:100097. doi: 10.1016/j.lanepe.2021.100097. Epub 2021 Apr 15.

BACKGROUND: To date, over 2 million people worldwide have died with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To describe the experience in Ireland, this study examined associations between underlying conditions and the following outcomes: mortality, admission to...

Cite
Bennett KE, Mullooly M, O'Loughlin M, et al. Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. Lancet Reg Health Eur. 2021;5:100097doi: 10.1016/j.lanepe.2021.100097.
Bennett, K. E., Mullooly, M., O'Loughlin, M., Fitzgerald, M., O'Donnell, J., O'Connor, L., Oza, A., & Cuddihy, J. (2021). Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. The Lancet regional health. Europe, 5100097. https://doi.org/10.1016/j.lanepe.2021.100097
Bennett, Kathleen E, et al. "Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study." The Lancet regional health. Europe vol. 5 (2021): 100097. doi: https://doi.org/10.1016/j.lanepe.2021.100097
Bennett KE, Mullooly M, O'Loughlin M, Fitzgerald M, O'Donnell J, O'Connor L, Oza A, Cuddihy J. Underlying conditions and risk of hospitalisation, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. Lancet Reg Health Eur. 2021 Jun;5:100097. doi: 10.1016/j.lanepe.2021.100097. Epub 2021 Apr 15. PMID: 33880459; PMCID: PMC8049357.
Copy Download .nbib Format: NLM
Lactate dehydrogenase activity staining demonstrates time-dependent immune cell infiltration in human ex-vivo burn-injured skin.

Scientific reports

Cuddihy J, Wu G, Ho L, Kudo H, Dannhorn A, Mandalia S, Collins D, Weir J, Spencer A, Vizcaychipi M, Takats Z, Nagy I.
PMID: 34711882
Sci Rep. 2021 Oct 28;11(1):21249. doi: 10.1038/s41598-021-00644-5.

Burn injuries constitute one of the most serious accidental injuries. Increased metabolic rate is a hallmark feature of burn injury. Visualising lactate dehydrogenase (LDH) activity has been previously used to identify metabolic activity differences, hence cell viability and burn...

Cite
Cuddihy J, Wu G, Ho L, et al. Lactate dehydrogenase activity staining demonstrates time-dependent immune cell infiltration in human ex-vivo burn-injured skin. Sci Rep. 2021;11(1):21249doi: 10.1038/s41598-021-00644-5.
Cuddihy, J., Wu, G., Ho, L., Kudo, H., Dannhorn, A., Mandalia, S., Collins, D., Weir, J., Spencer, A., Vizcaychipi, M., Takats, Z., & Nagy, I. (2021). Lactate dehydrogenase activity staining demonstrates time-dependent immune cell infiltration in human ex-vivo burn-injured skin. Scientific reports, 11(1), 21249. https://doi.org/10.1038/s41598-021-00644-5
Cuddihy, Joshua, et al. "Lactate dehydrogenase activity staining demonstrates time-dependent immune cell infiltration in human ex-vivo burn-injured skin." Scientific reports vol. 11,1 (2021): 21249. doi: https://doi.org/10.1038/s41598-021-00644-5
Cuddihy J, Wu G, Ho L, Kudo H, Dannhorn A, Mandalia S, Collins D, Weir J, Spencer A, Vizcaychipi M, Takats Z, Nagy I. Lactate dehydrogenase activity staining demonstrates time-dependent immune cell infiltration in human ex-vivo burn-injured skin. Sci Rep. 2021 Oct 28;11(1):21249. doi: 10.1038/s41598-021-00644-5. PMID: 34711882; PMCID: PMC8553775.
Copy Download .nbib Format: NLM
Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth.

Autophagy

Chen Y, Zhang Z, Henson ES, Cuddihy A, Haigh K, Wang R, Haigh JJ, Gibson SB.
PMID: 34530675
Autophagy. 2021 Sep 17;1-23. doi: 10.1080/15548627.2021.1973338. Epub 2021 Sep 17.

Cancer cell growth is dependent upon the sustainability of proliferative signaling and resisting cell death. Macroautophagy/autophagy promotes cancer cell growth by providing nutrients to cells and preventing cell death. This is in contrast to autophagy promoting cell death under...

Cite
Chen Y, Zhang Z, Henson ES, et al. Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth. Autophagy. 2021;1-23doi: 10.1080/15548627.2021.1973338.
Chen, Y., Zhang, Z., Henson, E. S., Cuddihy, A., Haigh, K., Wang, R., Haigh, J. J., & Gibson, S. B. (2021). Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth. Autophagy, 1-23. https://doi.org/10.1080/15548627.2021.1973338
Chen, Yongqiang, et al. "Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth." Autophagy vol. (2021): 1-23. doi: https://doi.org/10.1080/15548627.2021.1973338
Chen Y, Zhang Z, Henson ES, Cuddihy A, Haigh K, Wang R, Haigh JJ, Gibson SB. Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth. Autophagy. 2021 Sep 17;1-23. doi: 10.1080/15548627.2021.1973338. Epub 2021 Sep 17. PMID: 34530675.
Copy Download .nbib Format: NLM
Near-fatal Panton-Valentine leukocidin-positive .

World journal of critical care medicine

Cuddihy J, Patel S, Mughal N, Lockie C, Trimlett R, Ledot S, Cheshire N, Desai A, Singh S.
PMID: 34616664
World J Crit Care Med. 2021 Sep 09;10(5):301-309. doi: 10.5492/wjccm.v10.i5.301. eCollection 2021 Sep 09.

BACKGROUND: Panton-Valentine leukocidin (PVL) is an exotoxin secreted by CASE SUMMARY: An adolescent girl presented with haemoptysis and respiratory distress, deteriorated rapidly, with acute respiratory distress syndrome (ARDS) and profound shock requiring extensive, prolonged resuscitation, emergency critical care and...

Cite
Cuddihy J, Patel S, Mughal N, et al. Near-fatal Panton-Valentine leukocidin-positive . World J Crit Care Med. 2021;10(5):301-309doi: 10.5492/wjccm.v10.i5.301.
Cuddihy, J., Patel, S., Mughal, N., Lockie, C., Trimlett, R., Ledot, S., Cheshire, N., Desai, A., & Singh, S. (2021). Near-fatal Panton-Valentine leukocidin-positive . World journal of critical care medicine, 10(5), 301-309. https://doi.org/10.5492/wjccm.v10.i5.301
Cuddihy, Joshua, et al. "Near-fatal Panton-Valentine leukocidin-positive ." World journal of critical care medicine vol. 10,5 (2021): 301-309. doi: https://doi.org/10.5492/wjccm.v10.i5.301
Cuddihy J, Patel S, Mughal N, Lockie C, Trimlett R, Ledot S, Cheshire N, Desai A, Singh S. Near-fatal Panton-Valentine leukocidin-positive . World J Crit Care Med. 2021 Sep 09;10(5):301-309. doi: 10.5492/wjccm.v10.i5.301. eCollection 2021 Sep 09. PMID: 34616664; PMCID: PMC8462017.
Copy Download .nbib Format: NLM
Rudolf Ludwig Carl Virchow.

Cancer cells (Cold Spring Harbor, N.Y. : 1989)

Cuddihy J.
PMID: 2054259
Cancer Cells. 1991 Mar;3(3):110-2.

No abstract available.

Cite
Cuddihy J. Rudolf Ludwig Carl Virchow. Cancer Cells. 1991;3(3):110-2
Cuddihy, J. (1991). Rudolf Ludwig Carl Virchow. Cancer cells (Cold Spring Harbor, N.Y. : 1989), 3(3), 110-2.
Cuddihy, J. "Rudolf Ludwig Carl Virchow." Cancer cells (Cold Spring Harbor, N.Y. : 1989) vol. 3,3 (1991): 110-2.
Cuddihy J. Rudolf Ludwig Carl Virchow. Cancer Cells. 1991 Mar;3(3):110-2. PMID: 2054259.
Copy Download .nbib Format: NLM
On rate-dependent polycrystal deformation: the temperature sensitivity of cold dwell fatigue.

Proceedings. Mathematical, physical, and engineering sciences

Zhang Z, Cuddihy MA, Dunne FP.
PMID: 26528078
Proc Math Phys Eng Sci. 2015 Sep 08;471(2181):20150214. doi: 10.1098/rspa.2015.0214.

A temperature and rate-dependent crystal plasticity framework has been used to examine the temperature sensitivity of stress relaxation, creep and load shedding in model Ti-6Al polycrystal behaviour under dwell fatigue conditions. A temperature close to 120°C is found to...

Cite
Zhang Z, Cuddihy MA, Dunne FP. On rate-dependent polycrystal deformation: the temperature sensitivity of cold dwell fatigue. Proc Math Phys Eng Sci. 2015;471(2181):20150214doi: 10.1098/rspa.2015.0214.
Zhang, Z., Cuddihy, M. A., & Dunne, F. P. (2015). On rate-dependent polycrystal deformation: the temperature sensitivity of cold dwell fatigue. Proceedings. Mathematical, physical, and engineering sciences, 471(2181), 20150214. https://doi.org/10.1098/rspa.2015.0214
Zhang, Zhen, et al. "On rate-dependent polycrystal deformation: the temperature sensitivity of cold dwell fatigue." Proceedings. Mathematical, physical, and engineering sciences vol. 471,2181 (2015): 20150214. doi: https://doi.org/10.1098/rspa.2015.0214
Zhang Z, Cuddihy MA, Dunne FP. On rate-dependent polycrystal deformation: the temperature sensitivity of cold dwell fatigue. Proc Math Phys Eng Sci. 2015 Sep 08;471(2181):20150214. doi: 10.1098/rspa.2015.0214. PMID: 26528078; PMCID: PMC4614441.
Copy Download .nbib Format: NLM
Adolescent's perceptions of parental influences on physical activity.

International journal of adolescent medicine and health

Rachele JN, Cuddihy TF, Washington TL, McPhail SM.
PMID: 26812859
Int J Adolesc Med Health. 2016 Jan 21;29(3). doi: 10.1515/ijamh-2015-0093.

BACKGROUND: Youth physical activity engagement is a key component of contemporary health promotion strategies. Parents have potential to influence the physical activity behaviours of their children. The purpose of this study was to explore associations between adolescent self-reported physical...

Cite
Rachele JN, Cuddihy TF, Washington TL, et al. Adolescent's perceptions of parental influences on physical activity. Int J Adolesc Med Health. 2016;29(3)doi: 10.1515/ijamh-2015-0093.
Rachele, J. N., Cuddihy, T. F., Washington, T. L., & McPhail, S. M. (2016). Adolescent's perceptions of parental influences on physical activity. International journal of adolescent medicine and health, 29(3), . https://doi.org/10.1515/ijamh-2015-0093
Rachele, Jerome N, et al. "Adolescent's perceptions of parental influences on physical activity." International journal of adolescent medicine and health vol. 29,3 (2016). doi: https://doi.org/10.1515/ijamh-2015-0093
Rachele JN, Cuddihy TF, Washington TL, McPhail SM. Adolescent's perceptions of parental influences on physical activity. Int J Adolesc Med Health. 2016 Jan 21;29(3). doi: 10.1515/ijamh-2015-0093. PMID: 26812859.
Copy Download .nbib Format: NLM
Management of Acute Pancreatitis Associated With Checkpoint Inhibitors.

Journal of the advanced practitioner in oncology

Rogers BB, Cuddahy T, Zawislak C.
PMID: 33542849
J Adv Pract Oncol. 2020 Jan-Feb;11(1):49-62. doi: 10.6004/jadpro.2020.11.1.3. Epub 2020 Jan 01.

Pancreatitis is a rare immune-related adverse event (irAE) associated with the use of immune checkpoint inhibitors (ICIs). It is more often associated with combined immunotherapy than by any single agent. Early signs of pancreatitis may only include elevation of...

Cite
Rogers BB, Cuddahy T, Zawislak C. Management of Acute Pancreatitis Associated With Checkpoint Inhibitors. J Adv Pract Oncol. 2020;11(1):49-62doi: 10.6004/jadpro.2020.11.1.3.
Rogers, B. B., Cuddahy, T., & Zawislak, C. (2020). Management of Acute Pancreatitis Associated With Checkpoint Inhibitors. Journal of the advanced practitioner in oncology, 11(1), 49-62. https://doi.org/10.6004/jadpro.2020.11.1.3
Rogers, Barbara Barnes, et al. "Management of Acute Pancreatitis Associated With Checkpoint Inhibitors." Journal of the advanced practitioner in oncology vol. 11,1 (2020): 49-62. doi: https://doi.org/10.6004/jadpro.2020.11.1.3
Rogers BB, Cuddahy T, Zawislak C. Management of Acute Pancreatitis Associated With Checkpoint Inhibitors. J Adv Pract Oncol. 2020 Jan-Feb;11(1):49-62. doi: 10.6004/jadpro.2020.11.1.3. Epub 2020 Jan 01. PMID: 33542849; PMCID: PMC7517772.
Copy Download .nbib Format: NLM
No standarisation or harmonisation in anti-doping testing frequency.

BMJ open sport & exercise medicine

Cuddihy B.
PMID: 33062299
BMJ Open Sport Exerc Med. 2020 Sep 23;6(1):e000739. doi: 10.1136/bmjsem-2020-000793. eCollection 2020.

The use of performance-enhancing drugs (PEDs) has undermined the credibility of sports for many years, with cycling and athletics, especially badly hit. The World Anti-Doping Agency has been tasked with leading the fight against the use of PEDs in...

Cite
Cuddihy B. No standarisation or harmonisation in anti-doping testing frequency. BMJ Open Sport Exerc Med. 2020;6(1):e000739doi: 10.1136/bmjsem-2020-000793.
Cuddihy, B. (2020). No standarisation or harmonisation in anti-doping testing frequency. BMJ open sport & exercise medicine, 6(1), e000739. https://doi.org/10.1136/bmjsem-2020-000793
Cuddihy, Bill. "No standarisation or harmonisation in anti-doping testing frequency." BMJ open sport & exercise medicine vol. 6,1 (2020): e000739. doi: https://doi.org/10.1136/bmjsem-2020-000793
Cuddihy B. No standarisation or harmonisation in anti-doping testing frequency. BMJ Open Sport Exerc Med. 2020 Sep 23;6(1):e000739. doi: 10.1136/bmjsem-2020-000793. eCollection 2020. PMID: 33062299; PMCID: PMC7525253.
Copy Download .nbib Format: NLM
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?.

Pharmaceutics

Cuddihy G, Wasan EK, Di Y, Wasan KM.
PMID: 30813569
Pharmaceutics. 2019 Feb 26;11(3). doi: 10.3390/pharmaceutics11030099.

Parenteral amphotericin B has been considered as first-line therapy in the treatment of systemic fungal and parasitic infections, however its use has been associated with a number of limitations including affordability, accessibility, and an array of systemic toxicities. Until...

Cite
Cuddihy G, Wasan EK, Di Y, et al. The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?. Pharmaceutics. 2019;11(3)doi: 10.3390/pharmaceutics11030099.
Cuddihy, G., Wasan, E. K., Di, Y., & Wasan, K. M. (2019). The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?. Pharmaceutics, 11(3), . https://doi.org/10.3390/pharmaceutics11030099
Cuddihy, Grace, et al. "The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?." Pharmaceutics vol. 11,3 (2019). doi: https://doi.org/10.3390/pharmaceutics11030099
Cuddihy G, Wasan EK, Di Y, Wasan KM. The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?. Pharmaceutics. 2019 Feb 26;11(3). doi: 10.3390/pharmaceutics11030099. PMID: 30813569; PMCID: PMC6470859.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 29 entries